Comparison of 24-month treatment outcomes between as-needed treatment and switching to treat-and-extend in type 3 macular neovascularization

HIGHLIGHTS

• who: Jae Hui Kim from the Department have published the paper: Comparison of 24-month treatment outcomes between as-needed treatment and switching to treat-and-extend in type 3 macular neovascularization, in the Journal: Scientific Reports Scientific Reports
• what: The study was approved by the Institutional Review Board (IRB) of Kim`s Eye Hospital and conducted in accordance with the tenets of the Declaration of Helsinki. The authors believe the main reason for this difference is that the authors did not implement the standard as-needed regimen with monthly follow-up . In the present . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.